BG Medicine Story

BG Medicine Inc -- USA Stock  

USD 0.065  0.005  8.33%

Macroaxis does not monitor all media channels or aggregates social signals for BG Medicine. But even though we do not provide professional-grade financial sentiment analysis on BG Medicine Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for BG Medicine. Check also BG Medicine Hype Analysis, BG Medicine Correlation and BG Medicine Performance
Acquisition by Stelios Papadopoulos of 4205 shares of BG Medicine subject to Rule 16b-3
Filed transaction by Bg Medicine Inc director. Grant, award or other acquisition pursuant to Rule 16b-3

BG Medicine Inc insider trading alert for grant of stock option (right to buy) by Stelios Papadopoulos, the corporate stakeholder, on January 3, 2018. This event was filed by Bg Medicine Inc with SEC on 2013-06-14. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 25% . The overall trading delta when the story was published against the current closing price is 50% .

Similar stores for BG Medicine

over a week ago at www.macroaxis.com 
BG Medicine exotic insider transaction detected
Macroaxis News
Filed transaction by Bg Medicine Inc director. Unconventional Insider trading
over two weeks ago at http://www.dispatchtribunal.com 
BG Medicine and BioTelemetry Financial Analysis
patch News
Dispatch Tribunal - Jan 4, 2018 The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. Head-To-Head Comparison BG Medicine and BioTelemetry - Week Herald

Did you try this?

Run Volatility Analysis Now
   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
Hide  View All  NextLaunch Volatility Analysis

Return On Asset

Return On Asset Comparative Analysis
  Return On Asset 
      BG Medicine Comparables 
BG Medicine is currently under evaluation in return on asset category among related companies. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.